-
公开(公告)号:US11337427B2
公开(公告)日:2022-05-24
申请号:US16592462
申请日:2019-10-03
Inventor: Marit Otterlei , Siri Bachke
IPC: A01N63/50 , A61K38/17 , A61K38/14 , A61K38/16 , A61L2/16 , C07K14/00 , A61K38/00 , A61K31/165 , A61K31/35 , A61K31/397 , A61K31/43 , A61K31/496 , A61K31/7036 , A61K31/7048 , A61K41/00 , A61K45/06 , A61L2/10 , A01N25/08
Abstract: The present invention provides an agent, or a composition containing an agent, for use in treating or preventing a bacterial infection in a subject, wherein said agent comprises: (i) an oligopeptidic compound comprising a PCNA interacting motif and a domain that facilitates the cellular uptake of said compound, wherein the PCNA interacting motif is X1X2X3X4X5 (SEQ ID NO: 1) and wherein: X1 is a basic amino acid; X2 is an aromatic amino acid; X3 is an uncharged amino acid other than an aromatic amino acid, Glycine (G) and Proline (P); X4 is any amino acid other than Proline (P), an acidic amino acid or an aromatic amino acid; and X5 is a basic amino acid or Proline (P); or (ii) a nucleic acid molecule comprising a sequence encoding the oligopeptidic compound of (i). In certain aspects the agent and compositions of the invention may be used as single agents. In other aspects of the invention agents and compositions of the invention may be used in conjunction with one or more additional active agents, such as antibiotics.
-
公开(公告)号:US11261537B2
公开(公告)日:2022-03-01
申请号:US16679832
申请日:2019-11-11
Inventor: Bjørn-Ove Fimland , Dheeraj L. Dasa , Helge Weman
IPC: C30B25/10 , C30B25/18 , C30B29/40 , C30B29/48 , H01L21/02 , H01L29/15 , H01L29/20 , H01L29/22 , C30B29/02 , H01L29/04 , H01L29/16
Abstract: A composition of matter comprising a film on a graphitic substrate, said film having been grown epitaxially on said substrate, wherein said film comprises at least one group III-V compound or at least one group II-VI compound.
-
公开(公告)号:US20210015514A1
公开(公告)日:2021-01-21
申请号:US16623027
申请日:2018-06-08
Inventor: Per Even STORLI , Lars Cato REKSTAD , Brynjulf YSTGAARD
Abstract: A surgical retractor tool for removing an object from the stomach or from the oesophagus. The tool includes a flexible steerable tube for insertion into the body via the oral cavity and a gripper at the distal end of the tube for gripping an object in the stomach or the oesophagus in order to allow for removal of the object from the stomach or the oesophagus. The gripper includes first and second rotatable gripper surfaces and a clamping mechanism for moving the gripper surfaces to clamp the object. The rotatable gripper surfaces are arranged to rotate relative to the tube in order to allow a longitudinal axis of a gripped object to move into alignment with a longitudinal axis of the tube.
-
公开(公告)号:US10695067B2
公开(公告)日:2020-06-30
申请号:US15551385
申请日:2017-06-28
Inventor: Lars Cato Rekstad , Brynjulf Ystgaard
IPC: A61B17/115 , A61B17/072
Abstract: A surgical stapler includes a proximal end and a distal end and an anvil at the distal end for providing resistance to staples during the stapling operation of the surgical stapler. The anvil may include a number of segments arranged end-to-end. The anvil is elongated in the collapsed state, the anvil being elongated generally in a first direction D1. The anvil is configured such that the segments rotate about a rotation axis along a perpendicular second direction D2 when the anvil is actuated between the deployed and the collapsed states. The anvil is configured such that adjacent segments pivot relative to each other about a pivot axis along a third direction D3 when the anvil is actuated between the deployed and collapsed states. The stapler also includes an actuator mechanism, wherein the actuator mechanism is configured to be controlled from a location on the surgical stapler towards the proximal end.
-
公开(公告)号:US20190355868A1
公开(公告)日:2019-11-21
申请号:US16482915
申请日:2018-02-05
Inventor: Bjorn Ove Myking FIMLAND , Heige WEMAN , Dtngding REN
Abstract: A device, such as a light-emitting device, e.g. a laser device, comprising: a plurality of group III-V semiconductor NWs grown on one side of a graphitic substrate, preferably through the holes of an optional hole-patterned mask on said graphitic substrate; a first distributed Bragg reflector or metal mirror positioned substantially parallel to said graphitic substrate and positioned on the opposite side of said graphitic substrate to said NWs; optionally a second distributed Bragg reflector or metal mirror in contact with the top of at least a portion of said NWs; and wherein said NWs comprise aim-type doped region and a p-type doped region and optionally an intrinsic region there between.
-
公开(公告)号:US20180141977A1
公开(公告)日:2018-05-24
申请号:US15570837
申请日:2016-05-06
Inventor: Marit OTTERLEI , Siri BACHKE
CPC classification number: C07K14/003 , A61K38/1709 , A61K47/50 , A61L9/20 , A61L27/227 , C07K14/4738 , C12N5/0634 , Y02A50/402 , Y02A50/475 , Y02A50/478 , Y02A50/479 , Y02A50/481
Abstract: The present invention provides an agent, or a composition containing an agent, for use in treating or preventing a bacterial infection in a subject, wherein said agent comprises: (i) an oligopeptidic compound comprising a PCNA interacting motif and a domain that facilitates the cellular uptake of said compound, wherein the PCNA interacting motif is X1X2X3X4X5X6 (SEQ ID NO: 1) and wherein: X1 is a basic amino acid; X2 is an aromatic amino acid; X3 is an aromatic amino acid or a hydrophobic amino acid that has an R group comprising at least three carbon atoms; X4 is an uncharged amino acid other than an aromatic amino acid, Glycine (G) and Proline (P); X5 is any amino acid other than an acidic amino acid or an aromatic amino acid; and X6 is any amino acid other than an acidic amino acid or an aromatic amino add, preferably a basic amino add or Proline (P), wherein when X3 is not an aromatic amino acid, X5 is not lysine (K) and X6 is a basic amino acid or Proline (P): or (ii) a nucleic acid molecule comprising a sequence encoding the oligopeptidic compound of (i). In certain aspects the agent and composition of the invention may be used as single agents, in other aspects of the invention the agents and composition may be used in conjunction with one or more addition active agents, such as antibiotics, or in combination with UV radiation.
-
公开(公告)号:US20250013471A1
公开(公告)日:2025-01-09
申请号:US18694318
申请日:2022-09-23
Inventor: Magnus Jahre , Björn Gottschall , Lieven Eeckhout
Abstract: Profiling circuitry for a processor includes state-determining circuitry that is configured to access information stored by the processor for committing inflight instructions in program order, and to use this information to determine a commit state of the processor. The profiling circuitry also has sampling circuitry which is configured, when the processor is in a first commit state, to output sample data to a sample register or a memory that identifies one or more instructions that are next to be committed by the processor, and, when the processor is in a second commit state, to output sample data to the sample register or memory that identifies an instruction that was last committed by the processor.
-
公开(公告)号:US20250009659A1
公开(公告)日:2025-01-09
申请号:US18709728
申请日:2022-11-10
Applicant: UNIVERSITE DE RENNES , Centre National de la Recherche Scientifique , École Nationale Supérieure de Chimie de Rennes , Institut National des Sciences Appliquées de Rennes , Norwegian University of Science and Technology
Inventor: Thierry BENVEGNU , Thomas VIVES , Matthieu HICGUET , Sébastien SIMON , Johan SJÖBLOM
IPC: A61K9/127 , C07C69/608 , C07C219/10 , C07D249/04 , C08G65/00
Abstract: The present invention thus provides a novel family of liposomal compositions (nanocarriers), hereinafter referred to as Tetra-Acidosomes, comprising natural tetrameric acid (TA) lipids and/or novel chemically functionalized tetrameric acid (CFTA) lipids, for drug delivery applications.
-
公开(公告)号:US20230347314A1
公开(公告)日:2023-11-02
申请号:US18026683
申请日:2021-09-16
Inventor: Jon Otto FOSSUM , Josef BREU , Kristoffer HUNVIK , Patrick LOCH
CPC classification number: B01J20/12 , B01J20/3285 , B01D2253/11 , B01D2256/245 , B01D2257/504
Abstract: A smectite or vermiculite clay mineral in the form of a powder and having a plurality of layers wherein each layer comprises one octahedral type sheet sandwiched between two tetrahedral type sheets; wherein at least every other layer of said clay mineral comprises a hydroxide species comprising a cation selected from the group consisting of Ni, Mg, Fe, Mn or Zn.
-
公开(公告)号:US20230249136A1
公开(公告)日:2023-08-10
申请号:US18009916
申请日:2021-06-09
Inventor: Linfeng LEI , Arne LINDBRÅTHEN , Xuezhong HE
IPC: B01D71/02 , D01F2/02 , D01D5/24 , D01F9/16 , D01D5/06 , B01D53/22 , B01D69/02 , B01D69/08 , B01D67/00
CPC classification number: B01D71/021 , D01F2/02 , D01D5/24 , D01F9/16 , D01D5/06 , B01D53/228 , B01D69/02 , B01D69/08 , B01D67/0067 , D10B2201/22 , D10B2505/04 , B01D2053/224 , B01D2323/081 , B01D2325/0231 , B01D2325/0233 , B01D2325/20 , B01D2256/16 , B01D2257/504
Abstract: The present invention relates to a process for the production of asymmetric cellulose hollow fibres and the use of such fibres in the production of asymmetric carbon hollow fibre membranes (CHFMs). In particular, the present invention provides a facile and scalable process for the preparation of asymmetric CHFMs by direct pyrolysis of polymeric precursors without the need for complex pre-pyrolysis treatment steps to prevent pore collapse. The present invention also relates to the use of asymmetric CHFMs prepared according to said process in the separation of hydrogen gas from a mixed gas source, especially in the separation of hydrogen from CO2 in the steam-methane reforming reaction.
-
-
-
-
-
-
-
-
-